Dova Pharmaceuticals Inc (NASDAQ:DOVA) Insider Trading Activity – Director Bought 68,000 shares of Stock

ME Staff

6 years ago

Insider Trading Activity For Dova Pharmaceuticals Inc (NASDAQ:DOVA)

Paul B Manning , Director of Dova Pharmaceuticals Inc (NASDAQ:DOVA) reportedly Bought 68,000 shares of the company’s stock at an average price of 7.48 for a total transaction amount of $508,640.00 SEC Form

Insider Trading History For Dova Pharmaceuticals Inc (NASDAQ:DOVA)

On 7/5/2017 Steven M Goldman, Director, bought 72,000 with an average share price of $17.94 per share and the total transaction amounting to $1,291,680.00.

On 7/5/2017 Lee F Md Phd Allen, Insider, bought 3,500 with an average share price of $17.00 per share and the total transaction amounting to $59,500.00.

On 7/5/2017 Kevin Laliberte, VP, bought 6,200 with an average share price of $17.00 per share and the total transaction amounting to $105,400.00.

On 7/5/2017 Alex Sapir, CEO, bought 20,100 with an average share price of $17.00 per share and the total transaction amounting to $341,700.00.

On 8/15/2017 Steven M Goldman, Director, bought 20,169 with an average share price of $22.23 per share and the total transaction amounting to $448,356.87.

On 8/16/2017 Paul B Manning, Director, bought 25,870 with an average share price of $22.30 per share and the total transaction amounting to $576,901.00.

On 6/4/2018 Life Sciences Maste Perceptive, Major Shareholder, bought 10,000 with an average share price of $25.07 per share and the total transaction amounting to $250,700.00.

Analyst Ratings History For Dova Pharmaceuticals Inc (NASDAQ:DOVA)

On 3/23/2018 Evercore ISI Initiated Coverage of rating In to line with a price target of $29.00
On 7/15/2018 Jefferies Financial Group Reiterated Rating Buy with a price target of $40.00
On 8/29/2018 Raymond James Initiated Coverage of rating Outperform to Outperform with a price target of $44.00
On 9/4/2018 Leerink Swann Lower Price Target of rating Market Perform to Market Perform with a price target of $32.00 to $31.00
On 12/18/2018 LADENBURG THALM/SH SH Boost Price Target of rating Buy with a price target of $32.00
On 1/23/2019 JPMorgan Chase & Co. Downgraded rating Overweight to Underweight with a price target of $34.00 to $20.00
On 3/5/2019 HC Wainwright Set Price Target of rating Buy with a price target of $18.00

Recent Trading Activity for Dova Pharmaceuticals Inc (NASDAQ:DOVA)
Shares of Dova Pharmaceuticals Inc closed the previous trading session at with 146143 shares trading hands.